New Milestones in Late-Stage Milestone Payments
Executive Summary
We review late-stage development milestone fees paid from 2004 on, including some of the largest milestone payments yet made.
You may also be interested in...
Ranges of Biotech Regulatory Milestones
We list the ranges and averages of payments that have been paid over the past five years at common regulatory milestones.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.